share_log

Clearside Biomedical Q1 2024 GAAP EPS $(0.17) Misses $(0.14) Estimate, Sales $230.000K Miss $585.000K Estimate

Benzinga ·  May 9 17:28

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 13.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $230.000 thousand which missed the analyst consensus estimate of $585.000 thousand by 60.68 percent. This is a 5.65K percent increase over sales of $4.000 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment